Medi Assist Q2 FY27 consolidated PAT rises 167.6% to Rs 21.58 cr
For Q2 FY27, Medi Assist reported consolidated revenue from operations of Rs 241.51 cr and PAT of Rs 21.58 cr, up from Rs 8.07 cr a year earlier.
Key takeaways
- Rs 241.51 cr revenue from operations vs Rs 232.54 cr a year earlier
- Rs 245.36 cr total income vs Rs 234.82 cr in Q2 FY26
- Rs 215.63 cr total expenses vs Rs 221.35 cr a year earlier
- Rs 21.58 cr consolidated PAT vs Rs 8.07 cr in the prior-year quarter
- Basic EPS Rs 2.88 vs Rs 1.13 in the corresponding quarter last year
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 241.51 cr | Rs 232.54 cr | +3.9% |
| PAT | Rs 21.58 cr | Rs 8.07 cr | +167.6% |
| EPS | Rs 2.88 | Rs 1.13 | +154.9% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 8.94% of revenue, up 546 bps from 3.47%.
- Revenue rose 3.9% while total expenses fell 2.6%.
- Employee benefits took 42.9% of revenue, against 45.3% a year earlier.
• Revenue from operations (consolidated): Rs 241.51 cr vs Rs 232.54 cr in the quarter ended 30 September 2025
• Other income (consolidated): Rs 3.85 cr vs Rs 2.28 cr
• Total income (consolidated): Rs 245.36 cr vs Rs 234.82 cr
• Employee benefits expense (consolidated): Rs 103.59 cr vs Rs 105.45 cr
• Finance costs (consolidated): Rs 1.56 cr vs Rs 7.59 cr
• Depreciation and amortisation expenses (consolidated): Rs 21.79 cr vs Rs 20.93 cr
• Other expenses (consolidated): Rs 88.69 cr vs Rs 87.38 cr
• Total expenses (consolidated): Rs 215.63 cr vs Rs 221.35 cr
• Profit before exceptional items and tax (consolidated): Rs 29.73 cr vs Rs 13.47 cr
• Profit before tax (consolidated): Rs 29.73 cr vs Rs 13.47 cr
• Total income tax expense (consolidated): Rs 8.16 cr vs Rs 5.40 cr
• Profit for the period / year (PAT, consolidated): Rs 21.58 cr vs Rs 8.07 cr
• Basic EPS (consolidated, Rs): Rs 2.88 vs Rs 1.13
• Diluted EPS (consolidated, Rs): Rs 2.88 vs Rs 1.12
According to the statement of unaudited consolidated financial results for the quarter ended 30 September 2026, Medi Assist Healthcare Services Ltd’s consolidated revenue from operations for Q2 FY27 (quarter ended 30 September 2026) was Rs 241.51 cr, compared with Rs 232.54 cr in the corresponding quarter ended 30 September 2025. Total income rose to Rs 245.36 cr from Rs 234.82 cr over the same period.
Total expenses for the quarter were Rs 215.63 cr, down from Rs 221.35 cr in the quarter ended 30 September 2025. Within this, employee benefits expense was Rs 103.59 cr versus Rs 105.45 cr a year earlier, finance costs were Rs 1.56 cr versus Rs 7.59 cr, depreciation and amortisation expenses were Rs 21.79 cr versus Rs 20.93 cr, and other expenses were Rs 88.69 cr versus Rs 87.38 cr.
Profit before exceptional items and tax, which is also the reported profit before tax in this quarter as there were no exceptional items, stood at Rs 29.73 cr, compared with Rs 13.47 cr in the corresponding prior-year quarter. Total income tax expense was Rs 8.16 cr versus Rs 5.40 cr a year earlier. Profit for the period (profit after tax attributable to the group) increased to Rs 21.58 cr from Rs 8.07 cr in the quarter ended 30 September 2025, as per the statement of financial results.
The company also disclosed consolidated basic earnings per equity share (face value of Rs 5 each) of Rs 2.88 for the quarter, compared with Rs 1.13 in the corresponding quarter a year earlier, and diluted earnings per share of Rs 2.88 versus Rs 1.12, according to the same consolidated results table.
Track Medi Assist Healthcare Services Ltd
Cruxal reads every Medi Assist Healthcare Services Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.